Al-Dawaa Medical Services 4163.SR · SAR

Consumer Staples · Tadawul · 🇸🇦 Saudi Arabia

Compare

38.46

+0.73%

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 6.74bn

FY2017FY2025

Net income

SAR 321.8m

FY2017FY2025

Free cash flow

SAR 508.3m

FY2017FY2025

Shareholders' equity

SAR 1.45bn

FY2017FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	SAR 6.74bn	SAR 6.45bn	SAR 5.74bn	SAR 5.37bn	SAR 5.03bn	SAR 4.96bn	SAR 3.96bn	SAR 3.80bn	SAR 3.38bn
Gross profit	SAR 2.37bn	SAR 2.29bn	SAR 2.06bn	SAR 2.02bn	SAR 1.89bn	SAR 1.57bn	SAR 1.56bn	SAR 1.45bn	SAR 1.29bn
Operating income	SAR 485.0m	SAR 514.1m	SAR 466.7m	SAR 369.0m	SAR 267.9m	SAR 398.0m	SAR 300.6m	SAR 294.8m	SAR 210.4m
Net income	SAR 321.8m	SAR 370.1m	SAR 329.2m	SAR 305.4m	SAR 239.1m	SAR 246.4m	SAR 233.2m	SAR 228.3m	SAR 120.9m
Diluted earnings per share	3.79	4.35	3.87	3.59	2.81	1.61	1,166.02	2.69	1.42

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Total assets	SAR 5.23bn	SAR 5.04bn	SAR 4.71bn	SAR 4.50bn	SAR 4.03bn	SAR 3.54bn	SAR 3.14bn	SAR 3.01bn	SAR 2.94bn
Cash and short-term investments	—	SAR 49.3m	SAR 54.3m	SAR 139.0m	SAR 46.3m	SAR 38.1m	SAR 85.0m	SAR 107.7m	SAR 81.7m
Total liabilities	SAR 3.78bn	SAR 3.58bn	SAR 3.39bn	SAR 3.40bn	SAR 3.04bn	SAR 2.43bn	SAR 2.17bn	SAR 2.15bn	SAR 2.20bn
Debt	—	SAR 2.10bn	SAR 2.29bn	SAR 2.63bn	SAR 2.20bn	SAR 1.66bn	SAR 1.45bn	SAR 1.43bn	SAR 1.42bn
Shareholders' equity	SAR 1.45bn	SAR 1.46bn	SAR 1.31bn	SAR 1.10bn	SAR 989.2m	SAR 1.11bn	SAR 969.4m	SAR 863.2m	SAR 741.8m
Shares outstanding	85m	85m	85m	85m	85m	153m	0m	85m	85m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash from operations	SAR 660.0m	SAR 683.3m	SAR 725.7m	SAR 778.4m	SAR 670.1m	SAR 378.4m	SAR 515.0m	SAR 392.4m	SAR 567.9m
Capital spending	−SAR 151.7m	−SAR 228.7m	−SAR 223.6m	−SAR 287.6m	−SAR 320.2m	−SAR 215.1m	−SAR 155.6m	−SAR 139.2m	−SAR 229.5m
Free cash flow	SAR 508.3m	SAR 454.6m	SAR 502.1m	SAR 490.8m	SAR 350.0m	SAR 163.3m	SAR 359.4m	SAR 253.2m	SAR 338.5m
Dividends paid	−SAR 213.6m	−SAR 212.9m	−SAR 212.9m	−SAR 105.8m	−SAR 351.3m	−SAR 147.2m	−SAR 139.0m	−SAR 111.0m	−SAR 83.7m

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	SAR 1.64bn	SAR 1.55bn	SAR 1.68bn	SAR 1.70bn	SAR 1.69bn	SAR 1.65bn	SAR 1.72bn	SAR 1.63bn
Gross profit	SAR 653.0m	SAR 654.7m	SAR 585.5m	SAR 592.5m	SAR 590.5m	SAR 604.6m	SAR 582.6m	SAR 570.1m
Operating income	SAR 69.5m	SAR 56.0m	SAR 122.5m	SAR 103.1m	SAR 119.7m	SAR 139.6m	SAR 139.1m	SAR 110.2m
Net income	SAR 30.3m	SAR 22.3m	SAR 60.9m	SAR 69.1m	SAR 86.6m	SAR 105.2m	SAR 103.8m	SAR 75.1m
Diluted earnings per share	0.36	0.26	0.72	0.81	1.02	1.24	1.22	0.88
Cash from operations	−SAR 8.0m	SAR 134.0m	SAR 188.0m	SAR 190.0m	SAR 47.0m	SAR 233.0m	SAR 155.0m	SAR 179.0m
Capital spending	−SAR 33.0m	−SAR 18.0m	−SAR 55.0m	−SAR 40.0m	−SAR 25.0m	−SAR 30.0m	−SAR 56.0m	−SAR 81.0m
Free cash flow	−SAR 41.0m	SAR 116.0m	SAR 133.0m	SAR 150.0m	SAR 22.0m	SAR 203.0m	SAR 99.0m	SAR 98.0m
Total assets	SAR 5.40bn	SAR 5.69bn	SAR 5.23bn	SAR 5.17bn	SAR 5.38bn	SAR 5.21bn	SAR 5.04bn	SAR 5.01bn
Cash and short-term investments	—	—	—	SAR 49.6m	SAR 25.0m	SAR 86.5m	SAR 49.3m	SAR 61.9m
Debt	—	—	—	SAR 785.9m	SAR 805.1m	SAR 764.8m	SAR 821.9m	SAR 819.6m
Shareholders' equity	SAR 1.35bn	SAR 1.43bn	SAR 1.45bn	SAR 1.55bn	SAR 1.53bn	SAR 1.50bn	SAR 1.46bn	SAR 1.42bn

Financial ratios

Data as of 18 Oct 2026

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Gross margin	35.2%	35.5%	36.0%	37.6%	37.6%	31.7%
Operating margin	6.8%	8.0%	8.1%	8.0%	6.5%	6.4%
Net margin	4.8%	5.7%	5.7%	5.7%	4.8%	5.0%
Return on equity	22.2%	25.4%	25.1%	27.9%	24.2%	22.1%
Return on assets	6.1%	7.3%	7.0%	6.8%	5.9%	7.0%
Free cash flow yield	22.6%	23.4%	24.9%	26.7%	23.0%	7.2%
Revenue growth	4.4%	12.4%	6.9%	6.7%	1.5%	25.2%
Earnings growth	-13.1%	12.4%	7.8%	27.7%	-3.0%	5.7%
Current ratio	1.21x	1.15x	1.12x	1.10x	0.89x	1.08x
Debt to equity	0.00x	0.56x	0.75x	1.15x	1.45x	1.07x
Equity ratio	27.7%	28.9%	27.9%	24.4%	24.5%	31.4%
Interest coverage	3.56x	4.22x	3.75x	3.67x	3.97x	5.56x
Buybacks as a share of market value	0.0%	0.0%	0.0%	0.0%	44.6%	—

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	7.8%	6.3%	—
Operating income	9.5%	4.0%	—
Net income	1.7%	5.5%	—

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	35.4%	36.0%	35.6%	—

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022
Price to earnings	13.2	18.0	27.3	20.0
Price to sales	0.6	1.0	1.6	1.1

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 7 Jul 2026.

	FY2026	FY2025	FY2024	FY2023	FY2022
Paid in the year	1.89	2.52	2.505	3.75	1.25

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Al-Dawaa Medical Services 4163.SR · SAR

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology